Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the Amvia Pacemaker and Solia CSP S Pacing Lead on Conduction System Pacing

NCT06620237 is registered in ClinicalTrials.gov with Biotronik SE & Co. KG as lead sponsor.

NCT NCT06620237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06620237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the Amvia Pacemaker and Solia CSP S Pacing Lead on Conduction System Pacing
Lead sponsor
Biotronik SE & Co. KG
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 4, 2024
Completion date
September 30, 2027
Enrollment
152 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia, cardiac pacemaker, artificial, cardiac pacing, artificial, cardiac resynchronization therapy devices, conduction defect, cardiac, conduction disorder, heart failure